SenesTech Inc. CEO Files Form 4 on September 14
3 days ago
SenesTech Inc. CEO Michael Edell filed a Form 4 disclosure on September 14, confirming insider activity for the biotech company focused on biopesticides and senolytic therapies.
Investing.com Canada
Show all 24 updates